The burgeoning popularity of tirzepatide , initially for blood sugar control , is creating significant attention within the United Kingdom , prompting a notable shift in peptide trends. Availability these compounds remains a complex landscape, with public healthcare system coverage currently limited and specialist practices offering prescriptions a